D-dimer diagnostic role in thromboembolism: Difference between revisions
Rim Halaby (talk | contribs) Created page with "__NOTOC__ {{D-dimer}} {{CMG}} ==Overview== ==References== {{Reflist|2}} Category:Laboratory Test Category:Chemical pathology Category:Hematology Category:Fibr..." |
Rim Halaby (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
== D-dimer and Thromboembolism== | |||
=== Abnormal Levels === | |||
[[D-dimer|Plasma D-dimer]] levels > 500 ng/mL are abnormal.<ref name="pmid15096330">{{cite journal |author=Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, Biel RK, Bharadia V, Kalra NK |title=D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review |journal=[[Annals of Internal Medicine]] |volume=140 |issue=8 |pages=589–602 |year=2004 |month=April |pmid=15096330 |doi= |url= |accessdate=2012-05-07}}</ref> | |||
=== Sensitivity and Specificity === | |||
====Sensitivity<ref name="pmid15096330">{{cite journal |author=Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, Biel RK, Bharadia V, Kalra NK |title=D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review |journal=[[Annals of Internal Medicine]] |volume=140 |issue=8 |pages=589–602 |year=2004 |month=April |pmid=15096330 |doi= |url= |accessdate=2012-05-07}}</ref>==== | |||
[[ELISA]] ''(p=0.020)'', [[ELISA|quantitative rapid ELISA]] ''(p=0.016)'' and [[ELISA|semi-quantitative ELISA]] ''(p=0.047)'' are shown to be statistically superior to [[agglutination|whole-blood agglutination]]. | |||
====Specificity<ref name="pmid15096330">{{cite journal |author=Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, Biel RK, Bharadia V, Kalra NK |title=D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review |journal=[[Annals of Internal Medicine]] |volume=140 |issue=8 |pages=589–602 |year=2004 |month=April |pmid=15096330 |doi= |url= |accessdate=2012-05-07}}</ref>==== | |||
[[ELISA|Qualitative rapid ELISA]] has shown to be statistically superior to [[ELISA]] ''(p=0.004)'', [[ELISA|quantitative rapid ELISA]] ''(p=0.002)'', [[ELISA|semi-quantitative rapid ELISA]] ''(p=0.001)'', [[latex agglutination test|quantitative]] ''(p=0.005)'' and [[latex agglutination test|semi-quantitative]] latex agglutination assays ''(p=0.019)''. | |||
{| border="1" | |||
|+ | |||
! Method !! Sensitivity (95% CI) !! Specificity (95% CI) !! Positive Likelihood Ratio (95% CI) !! Negative Likelihood Ratio (95% CI) !! Time to obtain Results | |||
|- | |||
| [[ELISA|Enzyme-linked immunosorbent assay (ELISA)]] | |||
| align= "center" | 0.95 (0.85 to 1.00) | |||
| align= "center" | NS | |||
| align= "center" | NS | |||
| align= "center" | 0.13 (0.03 to 0.58) | |||
| align= "center" | ≥ 8 hours | |||
|- | |||
| [[ELISA|Quantitative rapid ELISA]] | |||
| align= "center" | 0.95 (0.83 to 1.00) | |||
| align= "center" | NS | |||
| align= "center" | NS | |||
| align= "center" | 0.13 (0.02 to 0.84) | |||
| align= "center" | 30 mins | |||
|- | |||
| [[ELISA|Semi-Quantitative rapid ELISA]] | |||
| align= "center" | 0.93 (0.79 to 1.00) | |||
| align= "center" | NS | |||
| align= "center" | NS | |||
| align= "center" | 0.20 (0.04 to 0.96) | |||
| align= "center" | 10 mins | |||
|- | |||
| [[ELISA|Qualitative rapid ELISA]] | |||
| align= "center" | NS | |||
| align= "center" | 0.68 (0.50 to 0.87) | |||
| align= "center" | NS | |||
| align= "center" | 0.11 (0.01 to 0.93) | |||
| align= "center" | 10 mins | |||
|- | |||
| [[Latex agglutination test|Quantitative Latex Agglutination]] | |||
| align= "center" | NS | |||
| align= "center" | NS | |||
| align= "center" | NS | |||
| align= "center" | NS | |||
| align= "center" | 10-15 mins | |||
|- | |||
| [[Latex agglutination test|Semi-quantitative Latex Agglutination]] | |||
| align= "center" | NS | |||
| align= "center" | NS | |||
| align= "center" | NS | |||
| align= "center" | 0.17 (0.04 to 0.78) | |||
| align= "center" | 5 mins | |||
|- | |||
| [[Latex agglutination test|Whole-Blood Agglutination]] | |||
| align= "center" | NS | |||
| align= "center" | 0.74 (0.60 to 0.88) | |||
| align= "center" | NS | |||
| align= "center" | NS | |||
| align= "center" | 2 mins | |||
=== Hemodynamically Stable Patients === | |||
====Incidence of Thromboembolic Events in Hemodynamically Stable Patients==== | |||
{| border="1" | |||
|+ | |||
! Condition !! Incidence of thromboembolic event (%) | |||
|- | |||
| Patients not receiving anticoagulation with negative CT findings. | |||
| 1.5%<ref name="pmid15858185">{{cite journal| author=Perrier A, Roy PM, Sanchez O, Le Gal G, Meyer G, Gourdier AL et al.|title=Multidetector-row computed tomography in suspected pulmonary embolism. | journal=N Engl J Med | year= 2005 | volume= 352|issue= 17 | pages= 1760-8 | pmid=15858185 | doi=10.1056/NEJMoa042905 | pmc=|url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15858185}} [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16118905Review in: J Fam Pract. 2005 Aug;54(8):653, 657] </ref><ref name="pmid16403929">{{cite journal| author=van Belle A, Büller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW et al.|title=Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. | journal=JAMA | year= 2006 | volume= 295 |issue= 2 | pages= 172-9 | pmid=16403929 | doi=10.1001/jama.295.2.172| pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16403929 }} </ref> | |||
|- | |||
| Patients with a high d-dimer level | |||
| 1.5% | |||
|- | |||
| Patients with a normal d-dimer level | |||
| 0.5%<ref name="pmid15858185">{{cite journal| author=Perrier A, Roy PM, Sanchez O, Le Gal G, Meyer G, Gourdier AL et al.|title=Multidetector-row computed tomography in suspected pulmonary embolism. | journal=N Engl J Med | year= 2005 | volume= 352|issue= 17 | pages= 1760-8 | pmid=15858185 | doi=10.1056/NEJMoa042905 | pmc=|url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15858185}} [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16118905Review in: J Fam Pract. 2005 Aug;54(8):653, 657] </ref> | |||
|} | |||
*[[Pulmonary embolism CT#Multi-Detector CT|Multidetector CT]] is indicated in hemodynamically stable patients with a high clinical probability of PE and/or patients with elevated plasma [[d-dimer]] levels secondary to the lack of specificity.<ref name="pmid16403929">{{cite journal| author=van Belle A, Büller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW et al.| title=Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. | journal=JAMA | year= 2006 | volume= 295 | issue= 2 | pages= 172-9 | pmid=16403929 | doi=10.1001/jama.295.2.172 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16403929 }} </ref><ref name="pmid19620439">{{cite journal| author=Gupta RT, Kakarla RK, Kirshenbaum KJ, Tapson VF| title=D-dimers and efficacy of clinical risk estimation algorithms: sensitivity in evaluation of acute pulmonary embolism. |journal=AJR Am J Roentgenol | year= 2009 | volume= 193 | issue= 2 | pages= 425-30 | pmid=19620439 |doi=10.2214/AJR.08.2186 | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19620439 }} </ref> | |||
*In patients with low-to-moderate suspicion of PE, a normal [[D-dimer]] level is considered sufficient to exclude the possibility of pulmonary embolism.<ref name="pmid8165626">{{cite journal |author=Bounameaux H, de Moerloose P, Perrier A, Reber G|title=Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview |journal=Thromb. Haemost.|volume=71 |issue=1 |pages=1-6 |year=1994 |pmid=8165626 |doi=}}</ref><ref name="pmid15096330">{{cite journal| author=Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R et al.| title=D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. | journal=Ann Intern Med | year= 2004 | volume= 140 | issue= 8 | pages= 589-602 | pmid=15096330 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15096330 }} [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15518461 Review in: ACP J Club. 2004 Nov-Dec;141(3):77] </ref><ref name="pmid20926499">{{cite journal| author=Bounameaux H, Perrier A, Righini M| title=Diagnosis of venous thromboembolism: an update. | journal=Vasc Med | year= 2010 | volume= 15 | issue= 5 | pages= 399-406 | pmid=20926499 | doi=10.1177/1358863X10378788 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20926499 }} </ref> | |||
=== Flowchart Summarizing the Role of D-dimer in the Diagnosis of PE === | |||
{{familytree/start |summary=Use of D-Dimer.}} | |||
{{familytree | | | | GMa | GMa=Patients with suspection of [[Pulmonary embolism]]}} | |||
{{familytree | |,|-|-|^|-|-|-|.| | | }} | |||
{{familytree |JOE| | | | |SIS| | | JOE=Clinically Low or Moderate|SIS=Clinically High}} | |||
{{familytree |,|^|-|.| | | | |!| }} | |||
{{familytree |!| | |!| | | | |!| }} | |||
{{familytree |!| | |ME| | |!|ME=D-Dimer Positive}} | |||
{{familytree |!| | | |!| | | |!| }} | |||
{{familytree |MOM| |!| | | |!| |MOM=D-Dimer Negative|}} | |||
{{familytree | |!| | |!| | | |!| }} | |||
{{familytree |GPa| |ME| |SIS|GPa=No treatment|ME=Further Tests|SIS=Further Tests}} | |||
{{familytree/end}} | |||
A new D-Dimer (DDMR) analyzer has shown to be more accurate in excluding patients with a low clinical pre-test probability.<ref name="pmid22245223">{{cite journal| author=Gosselin RC, Wu JR, Kottke-Marchant K, Peetz D, Christie DJ, Muth H et al.| title=Evaluation of the Stratus® CS Acute Care™ D-dimer assay (DDMR) using the Stratus® CS STAT Fluorometric Analyzer: A prospective multisite study for exclusion of pulmonary embolism and deep vein thrombosis. | journal=Thromb Res | year= 2012 | volume= | issue= | pages= | pmid=22245223 | doi=10.1016/j.thromres.2011.12.015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22245223 }} </ref> | |||
==References== | ==References== |
Revision as of 13:40, 25 September 2013
D-Dimer Microchapters |
Clinical Correlation |
---|
Clinical Trials |
D-dimer diagnostic role in thromboembolism On the Web |
American Roentgen Ray Society Images of D-dimer diagnostic role in thromboembolism |
Risk calculators and risk factors for D-dimer diagnostic role in thromboembolism |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
D-dimer and Thromboembolism
Abnormal Levels
Plasma D-dimer levels > 500 ng/mL are abnormal.[1]
Sensitivity and Specificity
Sensitivity[1]
ELISA (p=0.020), quantitative rapid ELISA (p=0.016) and semi-quantitative ELISA (p=0.047) are shown to be statistically superior to whole-blood agglutination.
Specificity[1]
Qualitative rapid ELISA has shown to be statistically superior to ELISA (p=0.004), quantitative rapid ELISA (p=0.002), semi-quantitative rapid ELISA (p=0.001), quantitative (p=0.005) and semi-quantitative latex agglutination assays (p=0.019).
Method | Sensitivity (95% CI) | Specificity (95% CI) | Positive Likelihood Ratio (95% CI) | Negative Likelihood Ratio (95% CI) | Time to obtain Results | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enzyme-linked immunosorbent assay (ELISA) | 0.95 (0.85 to 1.00) | NS | NS | 0.13 (0.03 to 0.58) | ≥ 8 hours | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantitative rapid ELISA | 0.95 (0.83 to 1.00) | NS | NS | 0.13 (0.02 to 0.84) | 30 mins | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Semi-Quantitative rapid ELISA | 0.93 (0.79 to 1.00) | NS | NS | 0.20 (0.04 to 0.96) | 10 mins | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Qualitative rapid ELISA | NS | 0.68 (0.50 to 0.87) | NS | 0.11 (0.01 to 0.93) | 10 mins | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantitative Latex Agglutination | NS | NS | NS | NS | 10-15 mins | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Semi-quantitative Latex Agglutination | NS | NS | NS | 0.17 (0.04 to 0.78) | 5 mins | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Whole-Blood Agglutination | NS | 0.74 (0.60 to 0.88) | NS | NS | 2 mins
Hemodynamically Stable PatientsIncidence of Thromboembolic Events in Hemodynamically Stable Patients
Flowchart Summarizing the Role of D-dimer in the Diagnosis of PE
References
|